{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:00:00Z","timestamp":1785387600345,"version":"3.55.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize the clinical and immunological features of rheumatoid arthritis (RA) patients with positive anti-centromere antibody (ACA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective case-control study, the clinical manifestations, demographic data, and immunological test results of these patients were collected and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ACA-positive RA patients exhibited a significantly higher prevalence of Raynaud\u2019s phenomenon (15.0% vs. 2.5%,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 4.838,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.028), xerostomia (22.5% vs. 8.8%,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 4.363,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.037), xerophthalmia (27.5% vs. 10.0%,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 6.128,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.013), and interstitial pneumonia (27.5% vs. 5.0%,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 12.343,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), as well as higher rates of elevated ALP (18.9% vs. 1.3%,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 9.780,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.002) and GGT (33.33% vs. 15.0%,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 5.086,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.024).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ACA-positive RA may present a unique phenotype characterized by an increased risk of interstitial lung disease, sicca symptoms, and cholestatic liver injury; thus, enhanced pulmonary\/hepatic screening and tailored monitoring strategies are critical.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1882422","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:20Z","timestamp":1785385340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and immunological features of rheumatoid arthritis patients with positive anti-centromere antibody: a case-control study"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiuqing","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]},{"name":"Department of Rheumatology and Clinical Immunology, Shandong Medical and Pharmaceutical University Hospital, Binzhou","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]},{"name":"Department of Rheumatology and Clinical Immunology, Ji\u2019an Central People\u2019s Hospital, Ji\u2019an","place":["Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Shandong Medical and Pharmaceutical University Hospital, Binzhou","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyi","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Shandong Medical and Pharmaceutical University Hospital, Binzhou","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis.","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","article-title":"Autoantibody to centromere (kinetochore) in scleroderma sera.","volume":"77","author":"Moroi","year":"1980","journal-title":"Proc Natl Acad Sci USA."},{"key":"B3","first-page":"277","article-title":"Anticentromere antibody-positive Ackerman\u2019s syndrome with granulomatous anterior uveitis.","volume":"42","author":"Fernandes","year":"2017","journal-title":"Acta Reumatol Port."},{"key":"B4","first-page":"1403","article-title":"Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.","volume":"27","author":"Nakano","year":"2000","journal-title":"J Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.55563\/clinexprheumatol\/o3pxq0","article-title":"Anticentromere antibody positive patients with primary Sjogren\u2019s syndrome have distinctive clinical and immunological characteristics.","volume":"41","author":"Liu","year":"2023","journal-title":"Clin Exp Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.dld.2024.12.024","article-title":"The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: enhancing the prognostic utility on the GLOBE scoring system.","volume":"57","author":"Ding","year":"2025","journal-title":"Dig Liver Dis."},{"key":"B7","first-page":"159","article-title":"Clinical significance of anti-centromere antibody in rheumatoid arthritis.","volume":"11","author":"Jearn","year":"2004","journal-title":"J Korean Rheum Assoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1038\/s41598-017-07137-4","article-title":"Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.","volume":"7","author":"Kuramoto","year":"2017","journal-title":"Sci Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: a American college of rheumatology\/European league against rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline.","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/ar3153","article-title":"The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients.","volume":"12","author":"Jearn","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41392-023-01370-2","article-title":"TGF-\u03b2 changes cyto\/mito-ribosome balance to target respiratory chain complex V biogenesis in pulmonary fibrosis therapy.","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis.","volume":"15","author":"Distler","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2332406","DOI":"10.1080\/07853890.2024.2332406","article-title":"The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.","volume":"56","author":"Wang","year":"2024","journal-title":"Ann Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1186\/ar2523","article-title":"Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination.","volume":"10","author":"Kidd","year":"2008","journal-title":"Arthritis Res Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e14298","DOI":"10.1111\/eci.14298","article-title":"Synovial expression of glucocorticoid receptor parallels fibroblast activation in patients with rheumatoid arthritis.","volume":"54","author":"Vlachogiannis","year":"2024","journal-title":"J Clin Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev."},{"key":"B20","first-page":"S403","article-title":"Anti-centromere antibodies are associated with more severe exocrine glandular dysfunction in primary Sj\u00f6gren\u2019s syndrome.","volume":"73","author":"Mahajan","year":"2021","journal-title":"Arthritis Care Res."},{"key":"B21","first-page":"230","article-title":"The politics of nature.","volume-title":"The Rise of Modern Genomics.","author":"Brown","year":"2001"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1882422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:22Z","timestamp":1785385342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1882422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":21,"alternative-id":["10.3389\/fmed.2026.1882422"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1882422","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1882422"}}